Has anyone been 'volunteered ' for this new trial from Astra Zanaca?
Saruparib (AZD5305) vs Placebo in Men with Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - EvoPAR-PR01
This is looking at whether adding a new drug on top of taking an Androgen Receptor Target Therapy (ARAT; such as abiraterone, darolutamide, enzalutamide) results in better outcomes (getting the cancer until control longer) than just taking an ARAT alone.
As this is a North American trial, would love to hear from others...
Written by
Max24
To view profiles and participate in discussions please or .
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.